title: Biological Perspectives: Huntington's Disease.
authors.affiliation: Private Practice, Fort Worth, Texas, USA.
authors.forename: Peter C
authors.initials: PC
authors.lastname: Kowalski
authors.affiliation: Department of Psychiatry, United States Air Force, San Antonio, Texas, USA.
authors.forename: David C
authors.initials: DC
authors.lastname: Belcher
authors.affiliation: School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama, USA.
authors.forename: Norman L
authors.initials: NL
authors.lastname: Keltner
authors.affiliation: Pediatric and Behavioral Health Service, Brooke Army Medical Center, San Antonio, Texas, USA.
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Dowben
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001569:Benzodiazepines / Q000008:administration & dosage; D001921:Brain / Q000473:pathology; D003072:Cognition Disorders; D003704:Dementia / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D006816:Huntington Disease / Q000150:complications* / Q000235:genetics*; D008279:Magnetic Resonance Imaging; D008297:Male; D008570:Memory, Short-Term; D019964:Mood Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy; D000077152:Olanzapine; D017374:Paroxetine / Q000008:administration & dosage
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D017374:Paroxetine; D000077152:Olanzapine